analysts who have always emphasized the fundamental role of anxiety in obsessional neurosis.,
The only prognostic criterion which Dr. Pollitt has found reliable, i.e. the length of time' the symptoms had been in continuous existence, has not, surprisingly, proved a guide in the prediction of the result of leucotomy. The most striking among Dr. Pippard's findings is the correlation between the effect of the operation and the personality feature of rigidity.< It seems that he has adopted a more limited concept of rigidity than most psychiatrists.
It is usually taken for granted that every obsessional neurotic must have a rigid: personality, but Dr. Pippard has made it clear that he does not hold this view.: He appears to refer to lack of social adaptability, which Partridge has found prognostically ominous, perhaps associated with affective rigidity. The main criterion of the rigid personality as it is generally understood, is its unmodifiable dependence on strict codes of behaviour and its lack of resilience in changing circumstances. Dr. Pippard's studies will prove of' considerable value for those psychiatrists who have to consider the indications for leucotomy. [June 12, 1956] Reserpine: Problems Associated with the Use of a So-called "Tranquillizing Agent" By MICHAEL SHEPHERD, M.A., D.M., D.P.M.
The Maudsley Hospital, London
RESERPE is one of the two most prominent representatives of that group of substances which have come to be widely known as the "tranquillizing agents". I shall try to review briefly what has been learnt about this drug, to summarize our own experience with it, an4 to indicate some of the important deficiencies in our knowledge, specifically about reserpine but by extension about its congeners. So far the mode of action of the drug is not clear and questions as important as its absorption, its distribution and fate within the body, and the long latent period before its action are still unanswered.
The property of the drug which has aroused the interest of most neuropsychiatrists and which is chiefly responsible for its reputation in the treatment of mental disorders consists in a supposedly distinctive sedative action. This differs from the condition associated with barbiturate administration in that while motor activity is subdued, sleep is not induced and the electroencephalographic patterns of sleep are not recorded; further, with human subjects relief from the distressing emotions associated with states of anxiety, agitation and tension has also been claimed. It is to such a complex cluster of phenomena that the term "tranquillization" has been applied. According to the Oxford English Dictionary the adjective "tranquil" is defined as "free from agitation or disturbance".
In the past three years the epithet "tranquillizing" has been vigorously applied to a number of pharmacologically diverse substances. The word is without scientific meaning and should not be employed as a nominal substitute for an understanding of the mode of action of the drug concerned. The need for this knowledge remains unsatisfied whether the drugs be called "tranquillizers", "ataraxics", "deturmoilizers" or "apatheticatory agents".
It is none the less easier to discard the term "tranquillization" than to replace it. Little progress in this direction has been made so far by the many laboratory studies on reserpine. Its actions on the nervous system extend beyond those described to account for its cardiovascular effects and, depending on the investigators' technique, reports have appeared of its action on the Iimbic system (MacLean et al., 1956) , on the mid-brain reticular substance (Rinaldi and Himwich, 1955) , on conditioned reflex responses (Gliedmann and Gantt, 1956) , and on cerebral synaptic transmission (Langfitt et al., 1956) . Ingenious biochemical speculations have assigned to reserpine a role as liberator of 5-hydroxytryptamine from binding-sites in the body and brain (Kuntzman et al., 1956) . It must be emphasized, however, that even if these physico-chemical reactions should be confirmed and elaborated they will remain incomplete without more knowledge of the complementary psychological changes which go with the response to reserpine. Interest in psycho-pharmacology has been reawakened among psychologists in recent years by the carefully controlled operant conditioning techniques associated with the work and views of Skinner (1953) . The chief problems set by these behavioural studies is that of relevance; the effects of reserpine on the pecking responses of pigeons, for example, can be accurately described and repeated but they are difficult to relate to the changes in behaviour brought about in schizophrenic patients. By contrast, the highly relevant modification of human behaviour and experience by pharmacological agents acting on the central nervous system has been systematically studied by very few workers, all of whom agree that the effects produced by these drugs in therapeutic doses depend in part on the personality of the subject and the circumstances of administration as well as on the physical properties of the drugs (von Felsinger et al., 1955) . Very little work of this type has been carried out with reserpine.
In these circumstances reserpine therefore presents a familiar problem to the clinical psychiatrist: namely, that of assessing the efficacy of a therapeutic agent about which too little knowledge has been accumulated, in the treatment of conditions whose etiology and natural history are for the most part imperfectly understood. When we began using reserpine at the Maudsley Hospital less than two years ago there were very few reliable accounts of its usein the treatment of neuropsychiatric conditions and almost no controlled clinical studies. Dr. D. L. Davies and I therefore conducted a clinical trial on a mixed group of out-patients, the majority of whom were suffering from anxiety and depressive reactions. The patients were given either reserpine, prescribed as Serpasil in a dose of 0 5 mg. by mouth twice daily, or a seemingly identical placebo, for a period of six weeks. The two substances were allotted by the hospital pharmacist who employed a random method and alone knew the nature of the drug dispensed to each patient; the usual crop of placebo reactions which was observed during the weekly examinations quickly demonstrated the importance of such precautions in testing patients of this type. At the end of the sixth week the response of each patient was estimated by rating scales which were completed by doctors and patients.
The results demonstrated a clear-cut difference in favour of those patients treated with reserpine but it was not possible in a clinical trial of this type to determine which factors would enable the clinician to select or reject individual patients or classes of patients for treatment (Davies and Shepherd, 1955 ).
An attempt was made to examine the efficacy of the drug in the treatment of a more homogeneous group, a small number of middle-aged males who presented an indisputable picture of involutional depression and who were reasonably expected to respond to a course of E.C.T. In the treatment of these cases any benefits of drug therapy could be measured against those predicted of a well-tried alternative procedure. The dose employed for these patients was much higher, between 10 and 15 mg. daily and was prescribed for three weeks, the period of time during which E.C.T. would otherwise have been administered. No clinical improvement was observed on reserpine; after a further week without treatment the patients were started on E.C.T.; all of them recovered after three weeks of this treatment. The value of the drug in the management of major depressive illness thus appeared dubious; this impression has since been strengthened by the results of Dr. Felix Post's carefully conducted trial of reserpine in the treatment of affective disorders arising in the senium.
The early claims made for reserpine rested on its use in the treatment of chronic mental illness. While the effects of reserpine on a disturbed patient population were being studied at Netherne Hospital, Dr. David Watt and I studied the response to medication of a group of schizophrenics who had resisted all previous treatment and had remained inactive and apathetic for many years (Shepherd and Watt, 1956) . 24 such patients could be found at St. John's Hospital, Buckinghamshire; all were female, with a mean age of 40 5 years and a mean hospital stay of 15-8 years. The prognosis was regarded as very poor in every case and a comparison of the effects of reserpine and chlorpromazine on the group was undertaken. The patients were allotted by a random method to three sub-groups of 8; a latin square design ensured that each sub-group received reserpine, chlorpromazine, and a placebo over three separate periods of six weeks, originally three times but later twice daily. The dose of reserpine was 10-15 mg. daily by mouth. Regular examinations for side-affects and toxicity were made and the patients' clinical state was rated at the end of each six-weekly period. The results indicated that in these conditions chlorpromazine was the drug of choice, not merely because the degree of improvement was greater but principally because the toxic or side-effects of reserpine in these doses were much more troublesome. The undesirable effects included marked restlessness, incontinence of urine and feces, sialorrhaea, bulimia, aedema of the face, convulsions and, most frequently, a well-marked extra-pyramidal syndrome.
The early reports on reserpine emphasized the relatively trivial nature of adverse reactions associated with its use. With the small doses used in the treatment of hypertension the commonest symptoms-lethargy, nasal obstruction, aching legs, and diarrhoea-were not regarded as more than inconvenient. Only when sufficient time had elapsed for therapy to continue over several months was it recognized that a small proportion of hypertensive patients, between 5% and 10% in most reports and frequently with a history of previous psychiatric disorder, developed psychiatric symptoms which were usually of a depressive been employed in neuropsychiatric practice, where the wide variation in dose-schedule indicates the empirical nature of the treatment. At one extreme 60 mg. daily have been administered to mental hospital patients (Kinross-Wright, 1955) ; elsewhere 2-5 mg. daily have been considered adequate for comparable populations (Kovitz et al., 1955; Rinaldi et al., 1956 ). Barsa and Kline (1956) have proposed an initial daily schedule of 5 mg.
intramuscularly and 3 mg. by mouth. The advocates of every regime, however, recognize the idiosyncrasies and unpredictable responses of individual patients and modify their doses constantly. During treatment some patients have suffered from an exacerbation of peptic ulcer symptoms, including perforation; the hyperchlorhydria induced by the drug has been studied experimentally (Schneider and Clark, 1956) .
Convulsions are now also recognized as a complication of treatment serious enough to contra-indicate E.C.T. during the period of drug administration (Foster and Gayle, 1955) ; experimentally, again, the drug has been shown to lower the seizure threshold in animals (Chen and Ensor, 1954) . Other disquieting complications of reserpine treatment which have been reported include cardiac failure, orthostatic collapse, dyspncea, hypothermia and thrombophlebitis, but none of these reactions occurs so frequently during treatment as the group of symptoms which, when fully developed, make up a neurological picture with all the features of post-encephalitic Parkinson's disease. While it has been shown that patients who were treated with doses of more than 30 mg. of reserpine daily all developed Parkinsonian symptoms (Kinross-Wright, 1955) , quantity cannot be the sole determining factor since some patients react in this way to doses of no more than 5 mg. daily (Stead and Wing, 1955) . Whether the neurological symptoms represent inconvenient side-effects of reserpine or provide evidence concerning its site of action remains undecided. The recent demonstration that these symptoms can be produced in primates by large doses of reserpine may provide an experimental approach to this question (Windle et al., 1956; Cole and Glees, 1956) . Since clinical experience meanwhile does not suggest that a favourable response to reserpine is dependent on the appearance of extra-pyramidal symptoms, continued administration of the drug beyond this point is inadvisable while doubt exists about the possibility of irreversible changes. Finally, reference should be made to the numerous clinical studies on reserpine which have been reported or are in progress. The drug has been used to treat most of the major psychiatric syndromes and also conditions as dissimilar as rheumatism, Huntington's chorea and enuresis. The majority of published studies report on the therapeutic results obtained with in-patients. Those which are favourable emphasize that symptomatic improvement rather than cure should be expected but they are less precise about the indications for treatment. Mielke's report from the university clinic at Zurich may be cited as one of the most clinically explicit; on the basis of his experience with nearly four hundred patients he presents 'the following list of symptoms as provisional indications for treatment: states of excitement, ,tension, feelings of unrest, stupor, negativism, mood changes and compulsive drives (Mielke, '1956 Which is implicit in the choice of these criteria little has been done to evaluate the powerful influence of the hospital or ward milieu on the behaviour of the patients treated. The tinteraction between the effects of reserpine and those of a group situation on the organism has been demonstrated experimentally on mice by Christian (1956) . At Netherne Hospital, ' where particular attention has been paid to the social aspects of mental hospital life and where teserpine has been administered to socially disturbed patients, the milieu in which treatment 'was given has proved to be a potent factor in determining the response of patients (Lancet, '1956; Wing, 1956) . Observations of this type may help explain, the discrepancies in the results obtained with reserpine by workers in different hospitals. Three questions remain unanswered by the many studies which have been carried out:
-firstly, whether a particular, self-terminating illness runs a shorter and more satisfactory course than would have been the case if it had been untreated or treated otherwise; secondly, whether patients with previously intractable mental disease who respond favourably to reserpine do or do not relapse at a later date; and thirdly, whether those patients who are benefited by treatment differ in an identifiable manner from those who are not. Information of this type is notoriously difficult to obtain about psychiatric out-patients, and an assessment of their response to treatment has been rendered still more difficult by the tendency to combine .the administration of reserpine with psychotherapeutic measures. UJntil these questions can be answered adequately reserpine will continue to stimulate interest among physiologists, pharmacologists' and biochemists working on the central nervous system but clinicians will *suspend judgnent about its value as a therapeutic agent.
